对《乳腺癌生物标志物：西班牙医学肿瘤学会和西班牙病理学会的共识声明》的勘误
Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
作者信息
Colomer R, Aranda-López I, Albanell J, García-Caballero T, Ciruelos E, López-García M Á, Cortés J, Rojo F, Martín M, Palacios-Calvo J
机构信息
Departamento de Oncología Médica, Hospital Universitario La Princesa, C/Diego de León, 62, 28006, Madrid, Spain.
Pathology Department, General University Hospital of Alicante, Alicante, Spain.
出版信息
Clin Transl Oncol. 2018 Aug;20(8):1093-1095. doi: 10.1007/s12094-018-1909-1.
Abstract
On page 5 of the article, in the last paragraph of the section "Prognostic genetic platforms: molecular phenotypes and translation to the clinic" a relevant discrepancy between the text and Table 1 could be misunderstood, therefore the paragraph was corrected.
摘要
在文章第5页“预后基因平台：分子表型及向临床转化”部分的最后一段，文本与表1之间的一个相关差异可能会被误解，因此对该段落进行了修正。
相似文献
1
Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.对《乳腺癌生物标志物：西班牙医学肿瘤学会和西班牙病理学会的共识声明》的勘误
Clin Transl Oncol. 2018 Aug;20(8):1093-1095. doi: 10.1007/s12094-018-1909-1.
2
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.乳腺癌的生物标志物：西班牙肿瘤内科学会和西班牙病理学会的共识声明。
Clin Transl Oncol. 2018 Jul;20(7):815-826. doi: 10.1007/s12094-017-1800-5. Epub 2017 Dec 22.
3
[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].西班牙病理学会和西班牙医学肿瘤学会关于乳腺癌生物标志物的共识声明
Rev Esp Patol. 2018 Apr-Jun;51(2):97-109. doi: 10.1016/j.patol.2017.12.002. Epub 2018 Mar 14.
4
Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.乳腺癌 2024 年的生物标志物：西班牙肿瘤内科学会和西班牙病理学会的最新共识声明。
Clin Transl Oncol. 2024 Dec;26(12):2935-2951. doi: 10.1007/s12094-024-03541-1. Epub 2024 Jun 13.
5
Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.更正：肿瘤学中的液体活检：西班牙病理学学会和西班牙医学肿瘤学学会的共识声明。
Clin Transl Oncol. 2020 Jun;22(6):961-962. doi: 10.1007/s12094-020-02313-x.
6
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.西班牙病理学协会和西班牙医学肿瘤学会关于胰腺和胆道癌生物标志物测定的专家共识。
Clin Transl Oncol. 2022 Nov;24(11):2107-2119. doi: 10.1007/s12094-022-02873-0. Epub 2022 Aug 25.
7
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.肿瘤液体活检：西班牙病理学会和西班牙肿瘤医学学会的共识声明。
Clin Transl Oncol. 2020 Jun;22(6):823-834. doi: 10.1007/s12094-019-02211-x. Epub 2019 Sep 26.
8
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.西班牙病理学学会和西班牙医学肿瘤学会关于胰腺和胆道癌生物标志物测定的专家共识
Rev Esp Patol. 2023 Jan-Mar;56(1):32-44. doi: 10.1016/j.patol.2022.06.004. Epub 2022 Aug 26.
9
[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].[上皮性卵巢癌生物标志物检测的建议。西班牙病理学会和西班牙医学肿瘤学会的全国共识声明]
Rev Esp Patol. 2018 Apr-Jun;51(2):84-96. doi: 10.1016/j.patol.2017.11.002. Epub 2018 Jan 17.
10
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).结直肠癌（CRC）生物标志物检测指南：西班牙病理学会（SEAP）和西班牙肿瘤内科学会（SEOM）的国家共识。
Clin Transl Oncol. 2012 Oct;14(10):726-39. doi: 10.1007/s12094-012-0856-5. Epub 2012 Jul 27.
本文引用的文献
1
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.《乳腺癌临床实践指南（NCCN 指南）》第 4 版 2017 年版
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.
2
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.降阶梯和升阶梯治疗早期乳腺癌：2017 年圣加仑国际早期乳腺癌专家共识会议关于早期乳腺癌的主要治疗。
Ann Oncol. 2017 Aug 1;28(8):1700-1712. doi: 10.1093/annonc/mdx308.
3
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.使用生物标志物指导早期浸润性乳腺癌女性辅助全身治疗决策：美国临床肿瘤学会临床实践指南重点更新
J Clin Oncol. 2017 Aug 20;35(24):2838-2847. doi: 10.1200/JCO.2017.74.0472. Epub 2017 Jul 10.
Zotero 插件